Ibandronic Acid Suppliers & Bulk Manufacturers

Available Forms: Oral tablet and Intravenous injection

Available Strengths: Tablet: 150 mg; Injection: 3mg/3ml

Reference Brands: Boniva® (US & EU); Bondronat®(EU)

Category: Women's Health

Ibandronic Acid (Bonviva® in the EU, Boniva® in the US) is a bisphosphonate used to treat and prevent postmenopausal osteoporosis. It reduces bone loss and fracture risk by inhibiting osteoclast activity. Available as a 150 mg oral tablet (monthly) or 3 mg IV injection (quarterly), it offers flexible dosing and high patient adherence. Widely marketed by Roche, it is a trusted option in B2B women’s health distribution across Europe and the United States. Ibandronic Acid is available in Oral tablet and Intravenous injection and strengths such as Tablet: 150 mg; Injection: 3mg/3ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ibandronic Acid is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ibandronic Acid can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ibandronic Acid (marketed as Bonviva® in the EU and Boniva® in the US) is a bisphosphonate used for the treatment and prevention of postmenopausal osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, increasing bone mineral density and reducing the risk of vertebral fractures. Available in oral 150 mg monthly tablets and 3 mg quarterly IV injections, Ibandronic Acid offers flexible dosing options to improve patient compliance. It is marketed in both regions by Roche and its affiliates, ensuring consistent quality and regulatory compliance. Ibandronic Acid is widely adopted in B2B pharmaceutical distribution for women’s health across Europe and North America.